Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation

Immunomodulatory therapies that improve the outcome of sepsis are not available. We sought to determine whether treatment of critically ill patients with sepsis with low-dose erythromycin —a macrolide antibioti...

Source: Critical Care - May 24, 2022 Category: Intensive Care Authors: Tom D. Y. Reijnders, Hessel Peters-Sengers, Lonneke A. van Vught, Fabrice Uhel, Marc J. M. Bonten, Olaf L. Cremer, Marcus J. Schultz, Martijn M. Stuiver and Tom van der Poll Tags: Research Source Type: research